Archive for the ‘Product Liability’ Category

Campaign Finance Threatens Political and Judicial Impartiality

February 18th, 2015

Back in November, we argued that in recent years campaign finance—especially among potential judges—has undermined Americans’ faith in the judicial branch. Thanks to ThePopTort.com, we’ve got more bad news on that front after only a few months’ time. The legal blog mentions the recent case of Altria, Philip Morris’ parent company, whose executives contributed half…


Drug Companies Spend Millions Marketing Redundant and Potentially Dangerous Treatments

February 4th, 2015

The investigative journalism website ProPublica, in conjunction with the New York Times medical blog The Upshot, recently published an article analyzing drug companies’ spending over the past five months in order to ascertain what drugs and medical devices they were promoting most heavily. The answer, it turns out, are medications that are not particularly cutting…


Pharmacy Linked to Fungal Meningitis Outbreak Faces Criminal Charges

January 7th, 2015

Back in October 2012, this blog began covering a fungal meningitis outbreak originating in Massachusetts that eventually killed sixty-four people and injured over 750 more across twenty states. Authorities traced the debilitating outbreak to the New England Compounding Center, a pharmaceutical company that provided personalized medications for medical professionals throughout the country. In the ensuing…


Generic Drugmaker Makes Potentially Dangerous Product, Sues FDA for Slowing Its Sale

December 17th, 2014

This blog has been covering issues related to generic drugs—warning labels, FDA oversight, and legal immunity—for more than a year, but this industry is nothing if not persistent. One of the largest manufacturers of generic pharmaceuticals in the world—Ranbaxy Laboratories, with net revenue of $2 billion in 2012—has provided material that lends itself to an…


Campaign Finance Undermines Americans’ Faith in Judicial Branch

November 19th, 2014

Tort reform is hardly a headline-grabbing subject, and it’s not all that often that a high-profile news outlet runs a thorough and insightful piece on the subject. The magazine Mother Jones has done so, however, in an article targeting interest groups’ financing of judicial elections called “Is Your Judge for Sale?” (thanks to civil justice…


Takata Air Bag Recall: Worse Than We Thought

November 12th, 2014

Back in July of this year, we published an article about a recall that happened at the same time as the 20 million-vehicle GM recall, which despite being nearly as dangerous was not as well-chronicled. While GM was trying to deal with cars that powered off without warning—deactivating power braking and power steering while vehicles…


Are Punitive Damages in Texas Punitive Enough?

October 29th, 2014

In mid-September of this year, a jury in Texas awarded Martha Salazar $73 million dollars—including $50 million in punitive damages—after she brought a lawsuit against Boston Scientific, the company responsible for manufacturing the Obtryx transvaginal mesh sling. Salazar, who received the pelvic implant to clear up minor urinary leakage at the age of 38, can…


Under Increased Scrutiny, Cracks Appear in Federal Auto Regulation

September 24th, 2014

The last time this blog posted an article on the massive (20 million cars and counting) recall issued by GM earlier this year, it was to report that federal regulators were beginning to suspect a cover-up among executives at the automotive company. More troubling, from an oversight perspective, is a recent investigation conducted by the…


After Approval, FDA Decides to Give Low-Testosterone Drugs a Second Look

September 17th, 2014

This past June, in an article about a potential link between testosterone treatment and cardiovascular problems, we explained that the FDA had (after about ten years of urging by researchers) decided to launch an investigation into the matter. It turns out that it only took a few months for our nation’s drug regulators to suspect…


Yaz Birth Control: Federal Oversight, Conflicts of Interest, and a Billion-Dollar Settlement

September 3rd, 2014

On the topic of birth control, this blog has focused much of its attention on the NuvaRing, whose links to deep vein thrombosis, pulmonary embolism, and death (among other side effects) resulted in a $100 million settlement spread over 700 plaintiffs. Were every patient to accept this offer, each would see a payout of about…


 
 
© 2015 Feldman Shepherd Wohlgelernter Tanner Weinstock & Dodig LLP         Attorney Advertising         Disclaimer         Privacy Policy         Site Map
Personal Injury | Medical Malpractice | Auto Defects | Forklift Accidents | Tire Defects | Cerebral Palsy | Construction Accidents | Crashworthiness | Spinal Injury | Product Liability | Car Fires | Air Bag Defects